Clinical Trial: Research on the Role of SLC1A5 in the Development of Esophageal Cancer
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Research on the Role of the Amino Acid Transporter SLC1A5 in the Development of Esophageal Cancer
Brief Summary: To explore the significance of Solute Carrier Family 1 Member 5 (SLC1A5) in the occurrence of esophageal cancer, by comparing the expression of SLC1A5 between esophageal cancer tissues and adjacent tissues.
Detailed Summary:
This will be an observational study. The investigators will aim to enroll 100 male and female adult patients (aged 18 years and over) of all ethnicities/races, who have been referred to the Fourth Affiliated Hospital of Guangxi Medical University for esophageal cancer.
The investigators will be using a standardized data collection form. This is an observational study in which standard of care will be practiced and the patients are not placed at additional risk from participating in this study. However, as the investigators are collecting data prospectively, all participants will sign consent. An attempt will be made to see if there is a correlation between the expression of SLC1A5 with esophageal cancer.
Sponsor: Fourth Affiliated Hospital of Guangxi Medical University
Current Primary Outcome: optical density (ODs) of each slice by immunohistochemistry assay [ Time Frame: within one year (plus or minus 1 month) after surgery ]
Original Primary Outcome: Same as current
Current Secondary Outcome: SLC1A5 expression detected by WesternBlot [ Time Frame: within one year (plus or minus 1 month) after surgery ]
Original Secondary Outcome: Same as current
Information By: Fourth Affiliated Hospital of Guangxi Medical University
Dates:
Date Received: December 6, 2015
Date Started: December 2015
Date Completion: August 2018
Last Updated: August 11, 2016
Last Verified: August 2016